483 related articles for article (PubMed ID: 19191643)
21. Clinical experiences of pulmonary and bloodstream nocardiosis in two tertiary care hospitals in northern Taiwan, 2000-2004.
Tuo MH; Tsai YH; Tseng HK; Wang WS; Liu CP; Lee CM
J Microbiol Immunol Infect; 2008 Apr; 41(2):130-6. PubMed ID: 18473100
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy.
Tuon FF; Gortz LW; Rocha JL
Braz J Infect Dis; 2012; 16(4):351-6. PubMed ID: 22846123
[TBL] [Abstract][Full Text] [Related]
23. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates.
El Amari EB; Chamot E; Auckenthaler R; Pechère JC; Van Delden C
Clin Infect Dis; 2001 Dec; 33(11):1859-64. PubMed ID: 11692297
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
25. A five-year review of Pseudomonas aeruginosa bacteremia in children hospitalized at a single center in southern China.
Zhang Q; Smith JC; Zhu Q; Guo Z; MacDonald NE
Int J Infect Dis; 2012 Aug; 16(8):e628-32. PubMed ID: 22709682
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer.
Ohmagari N; Hanna H; Graviss L; Hackett B; Perego C; Gonzalez V; Dvorak T; Hogan H; Hachem R; Rolston K; Raad I
Cancer; 2005 Jul; 104(1):205-12. PubMed ID: 15880433
[TBL] [Abstract][Full Text] [Related]
28. [The spectrum of bronchopulmonary infection caused by Pseudomonas aeruginosa in patients infected with the human immunodeficiency virus].
Santín Cerezales M; Aranda Sánchez M; Podzamczer Palter D; Maiques Llacer JM; Rufí Rigau G; Gudiol Munté F
Rev Clin Esp; 1996 Oct; 196(10):692-7. PubMed ID: 9005472
[TBL] [Abstract][Full Text] [Related]
29. Clinical predictors of Pseudomonas aeruginosa bacteremia among Gram-negative bacterial infections in non-neutropenic patients with solid tumor.
Joo EJ; Kang CI; Ha YE; Kim J; Kang SJ; Park SY; Lee NY; Wi YM; Chung DR; Peck KR; Song JH
J Infect; 2011 Sep; 63(3):207-14. PubMed ID: 21777616
[TBL] [Abstract][Full Text] [Related]
30. Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
Chiang WC; Chen SY; Chien KL; Wu GH; Yen AM; Su CP; Lee CC; Chen YC; Chang SC; Chen SC; Chen WJ; Chen TH
Am J Emerg Med; 2007 Jul; 25(6):597-607. PubMed ID: 17606081
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for Pseudomonas aeruginosa bacteremia in Thai patients.
Siripassorn K; Santiprasitkul S; Udompanthurak S; Thamlikitkul V
J Med Assoc Thai; 2002 Oct; 85(10):1095-9. PubMed ID: 12501901
[TBL] [Abstract][Full Text] [Related]
32. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M
Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
[TBL] [Abstract][Full Text] [Related]
33. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.
Tam VH; Chang KT; Schilling AN; LaRocco MT; Genty LO; Garey KW
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):279-85. PubMed ID: 19135330
[TBL] [Abstract][Full Text] [Related]
34. Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes.
López Dupla M; Martinez JA; Vidal F; Almela M; López J; Marco F; Soriano A; Richart C; Mensa J
J Intern Med; 2005 Aug; 258(2):172-80. PubMed ID: 16018794
[TBL] [Abstract][Full Text] [Related]
35. Pseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden C
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S71-5. PubMed ID: 17698326
[TBL] [Abstract][Full Text] [Related]
36. [Respiratory infection caused by Pseudomonas aeruginosa in patients with HIV infection].
Arrizabalaga Aguirreazaldegui J; Horcajada Gallego JP; Mentxaka Ugalde B; Rodríguez Arrondo F; Iribarren Loyarte JA; von Wichman de Miguel M; Garde Orbaiz C
Rev Clin Esp; 1996 Oct; 196(10):678-83. PubMed ID: 9005470
[TBL] [Abstract][Full Text] [Related]
37. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults.
Hashimoto M; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Kokudo N; Makuuchi M
Transpl Infect Dis; 2009 Feb; 11(1):11-9. PubMed ID: 18811632
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for nosocomial urinary tract-related bacteremia: a case-control study.
Saint S; Kaufman SR; Rogers MA; Baker PD; Boyko EJ; Lipsky BA
Am J Infect Control; 2006 Sep; 34(7):401-7. PubMed ID: 16945684
[TBL] [Abstract][Full Text] [Related]
39. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
[TBL] [Abstract][Full Text] [Related]
40. Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome.
Nguyen LH; Hsu DI; Ganapathy V; Shriner K; Wong-Beringer A
J Antimicrob Chemother; 2008 Mar; 61(3):714-20. PubMed ID: 18222951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
